Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune Parameters and COVID-19 Infection – Associations With Clinical Severity and Disease Prognosis
Miloš Jeseňák, Miroslava Brndiarová, Ingrid Urbančíková, et al.
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 116

Showing 26-50 of 116 citing articles:

Characterization of T lymphocytes in severe COVID‐19 patients
Daniela Fenoglio, Chiara Dentone, Alessia Parodi, et al.
Journal of Medical Virology (2021) Vol. 93, Iss. 9, pp. 5608-5613
Open Access | Times Cited: 28
A cytokine panel and procalcitonin in COVID-19, a comparison between intensive care and non-intensive care patients
Tina Mazaheri, Ruvini Ranasinghe, Wiaam Al‐Hasani, et al.
PLoS ONE (2022) Vol. 17, Iss. 5, pp. e0266652-e0266652
Open Access | Times Cited: 19
Does Follow-up D-Dimer Level Help in Predicting Oxygenation Status, Ventilatory Support Requirement, Lung Fibrosis, and Thromboembolic Events in Coronavirus Disease 2019 Pneumonia? A Prospective Observational Study in a Tertiary Care Setting in India
Shital Patil, Abhijit Acharya, Gajanan Gondhali, et al.
Annals of African Medicine (2023) Vol. 22, Iss. 3, pp. 286-292
Open Access | Times Cited: 10
Perspective of HLA-G Induced Immunosuppression in SARS-CoV-2 Infection
Aifen Lin, Wei‐Hua Yan
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 25
Sea Urchin Pigments: Echinochrome A and Its Potential Implication in the Cytokine Storm Syndrome
Tamara Rubilar, Elena S. Barbieri, Ayelén Gázquez, et al.
Marine Drugs (2021) Vol. 19, Iss. 5, pp. 267-267
Open Access | Times Cited: 23
Immune system changes in those with hypertension when infected with SARS-CoV-2
Sheng Su, Ruirong Chen, Shaofen Zhang, et al.
Cellular Immunology (2022) Vol. 378, pp. 104562-104562
Open Access | Times Cited: 16
Effectiveness of mid-regional pro-adrenomedullin, compared to other biomarkers (including lymphocyte subpopulations and immunoglobulins), as a prognostic biomarker in COVID-19 critically ill patients: New evidence from a 15-month observational prospective study
Giorgia Montrucchio, Gabriele Sales, Eleonora Balzani, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 9
Silent existence of eosinopenia in sepsis: a systematic review and meta-analysis
Yao Lin, Jiabing Rong, Zhaocai Zhang
BMC Infectious Diseases (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 22
Modulation of Host Immune Response Is an Alternative Strategy to Combat SARS-CoV-2 Pathogenesis
Lakhveer Singh, Sakshi Bajaj, Manoj Gadewar, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 21
Inhibitory Immune Checkpoint Molecules and Exhaustion of T cells in COVID-19
Martina Barnova, Anna Bobcakova, Veronika Urdova, et al.
Physiological Research (2021), pp. S227-S247
Open Access | Times Cited: 21
T cell counts and IL-6 concentration in blood of North African COVID-19 patients are two independent prognostic factors for severe disease and death
Brahim Belaid, Lydia Lamara Mahammed, Belgacem Mihi, et al.
Journal of Leukocyte Biology (2021) Vol. 111, Iss. 1, pp. 269-281
Open Access | Times Cited: 21
Hyperinflammatory State and Low T1 Adaptive Immune Response in Severe and Critical Acute COVID-19 Patients
Mercedes García‐Gasalla, María Berman-Riu, Jaime Pons, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 14
Impaired SARS-CoV-2 specific T-cell response in patients with severe COVID-19
Lidewij W. Rümke, Wouter L. Smit, Ailko Bossink, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
IL-6 and Neutrophil/Lymphocyte Ratio as Markers of ICU Admittance in SARS-CoV-2 Patients with Diabetes
Iulia Făgărășan, Adriana Rusu, Horaţiu Comşa, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14908-14908
Open Access | Times Cited: 8
The effect of the COVID‐19 lockdown on children with asthma‐related symptoms: A tertiary care center experience
Inbal Golan‐Tripto, Noga Arwas, Michal Maimon, et al.
Pediatric Pulmonology (2021) Vol. 56, Iss. 9, pp. 2825-2832
Open Access | Times Cited: 19
CT characteristics and laboratory findings of COVID-19 pneumonia in relation to patient outcome
Ibrahim A. I. Mohamed, Hosam A. Hasan, Mohamed Abdel-Tawab
The Egyptian Journal of Radiology and Nuclear Medicine (2021) Vol. 52, Iss. 1
Open Access | Times Cited: 18
Activated CD8+CD38+ Cells Are Associated With Worse Clinical Outcome in Hospitalized COVID-19 Patients
Anna Bobcakova, Martina Barnova, Róbert Vyšehradský, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13
Molnupiravir as an Early Treatment for COVID-19: A Real Life Study
Michela Pontolillo, Claudio Ucciferri, Paola Borrelli, et al.
Pathogens (2022) Vol. 11, Iss. 10, pp. 1121-1121
Open Access | Times Cited: 13
Role of D-Dimer in Covid-19 pneumonia: sensitive marker of inflammation, predictor of mechanical ventilation, thromboembolic events and early marker of post covid-lung fibrosis; Prospective Multicentric, Observational, Interventional study in tertiary care setting in India
Shital Patil, Manojkumar Bhadake, Abhijit Acharya, et al.
The Journal of Medical Research (2022) Vol. 8, Iss. 2, pp. 50-55
Open Access | Times Cited: 12
Colchicine protects against the development of experimental abdominal aortic aneurysm
Yi Zhao, Qirui Shen, Yuxin Chen, et al.
Clinical Science (2023) Vol. 137, Iss. 19, pp. 1533-1545
Open Access | Times Cited: 7
D-dimer in Coronavirus Disease 2019 pneumonia: A valuable inflammatory marker in predicting trends of systemic effects in addition to thromboembolic events! A single-center experience
Shital Patil, Sham Toshniwal, Shubhangi Khule
Journal of Applied Sciences and Clinical Practice (2023) Vol. 4, Iss. 2, pp. 116-123
Open Access | Times Cited: 7
Revisiting matrix metalloproteinase 12: its role in pathophysiology of asthma and related pulmonary diseases
Khalid Abd‐Elaziz, Miloš Jeseňák, Martina Vašáková, et al.
Current Opinion in Pulmonary Medicine (2020) Vol. 27, Iss. 1, pp. 54-60
Open Access | Times Cited: 20
Do Blood Eosinophils Predict in-Hospital Mortality or Severity of Disease in SARS-CoV-2 Infection? A Retrospective Multicenter Study
Pierrick Le Borgne, Laure Abensur Vuillaume, Karine Alamé, et al.
Microorganisms (2021) Vol. 9, Iss. 2, pp. 334-334
Open Access | Times Cited: 17
Comprehensive overview of COVID-19-related respiratory failure: focus on cellular interactions
Fahimeh Zamani Rarani, Mohammad Mahdi Zamani, Michael R. Hamblin, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 11
A review of the main genetic factors influencing the course of COVID-19 in Sardinia: the role of human leukocyte antigen-G
Stefano Mocci, Roberto Littera, Luchino Chessa, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6

Scroll to top